Prosecution Insights
Last updated: November 15, 2026

Guangzhou Kingmed Diagnostics Group Co. Ltd.

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Guangzhou Kingmed Diagnostics Group Co. Ltd. is currently prosecuting 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This action is being handled by 1 distinct examiner, indicating a focused prosecution strategy. The portfolio is also confined to 1 distinct art unit, suggesting that the company's diagnostic innovations are technically focused within a specific area of biotechnology. This concentration allows the legal team to apply a consistent set of arguments and technical disclosures to the pending matter.

The busiest examiner for this portfolio is LIN, JERRY, who is handling the 1 busiest examiner pending office action. As the only examiner currently engaged with the company, LIN, JERRY is the primary gatekeeper for its intellectual property goals. Practitioners should prioritize understanding this examiner's specific concerns and examination history. The involvement of only 1 distinct examiner means that the company can focus its efforts on a single, critical relationship at the USPTO to advance its diagnostic claims.

The presence of 1 pending office action indicates that the portfolio is in a focused stage of examination. Since the 1 distinct examiner is also the busiest examiner, the outcome of this single action will define the portfolio's immediate success. This streamlined structure within 1 distinct art unit simplifies the administrative burden and allows for a more direct and efficient path toward securing patent protection for the company's medical diagnostic technology.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
LIN, JERRY 1 72.1% +14.7%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18019858 METHOD FOR DETECTING UNIPARENTAL DISOMY BASED UPON NGS-TRIO, AND USE THEREOF LIN, JERRY —

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18019858 METHOD FOR DETECTING UNIPARENTAL DISOMY BASED UPON NGS-TRIO, AND USE THEREOF LIN, JERRY —

Top Art Units

Art UnitApps
1685 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18019858 METHOD FOR DETECTING UNIPARENTAL DISOMY BASED UPON NGS-TRIO, AND USE THEREOF LIN, JERRY 1685 §101§102§112 Non-Final OA — Pending Feb 06, 2023

Managing Guangzhou Kingmed Diagnostics Group Co. Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Guangzhou Kingmed Diagnostics Group Co. Ltd. have?

Guangzhou Kingmed Diagnostics Group Co. Ltd. has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Guangzhou Kingmed Diagnostics Group Co. Ltd. applications?

Jerry Lin has the most, with 1 of Guangzhou Kingmed Diagnostics Group Co. Ltd.'s pending office actions.

What technology area are Guangzhou Kingmed Diagnostics Group Co. Ltd.'s patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month